Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ILT2/CD85j/LILRB1 Antibody (HP-F1) - Azide and BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
$243.50 - $501.50
Specifications
| Antigen | ILT2/CD85j/LILRB1 |
|---|---|
| Clone | HP-F1 |
| Concentration | 1 mg/mL |
| Dilution | Flow Cytometry 1:10-1:1000, Functional |
| Applications | Flow Cytometry, Functional Assay |
| Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
|
NB018520
|
Novus Biologicals
NBP1429980.025MG |
0.025 mg |
Each for $243.50
|
|
|||||
|
NBP142998A
|
Novus Biologicals
NBP1429980.1MG |
0.1 mg |
Each for $501.50
|
|
|||||
Description
ILT2/CD85j/LILRB1 Monoclonal specifically detects ILT2/CD85j/LILRB1 in Human samples. It is validated for Flow Cytometry, Functional, CyTOF-ready.Specifications
| ILT2/CD85j/LILRB1 | |
| 1 mg/mL | |
| Flow Cytometry, Functional Assay | |
| Unconjugated | |
| Mouse | |
| Human | |
| CD85 antigen-like family member J, CD85j, CD85j antigen, Ig-like transcript 2, ILT-2, ILT2FLJ37515, Immunoglobulin-like transcript 2, leukocyte Ig-like receptor-1, Leukocyte immunoglobulin-like receptor 1, leukocyte immunoglobulin-like receptor subfamily B member 1, leukocyte immunoglobulin-like receptor subfamily B member 1 soluble isoform, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), LIR1LIR-1MIR-7CD85MIR7CD85 antigen, member 1, Monocyte/macrophage immunoglobulin-like receptor 7 | |
| LILRB1 | |
| IgG1 κ | |
| Protein A or G purified |
| HP-F1 | |
| Flow Cytometry 1:10-1:1000, Functional | |
| Monoclonal | |
| Purified | |
| RUO | |
| Aqueous, may contain carrier protein/stabilizer. with No Preservative | |
| 10859 | |
| The immunogen for this antibody was CD85j. | |
| Primary | |
| Store at 4C. Do not freeze. |
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title